(Q57313781)

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Contradicted and initially stronger effects in highly cited clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Why current publication practices may distort science

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Systematic review of the empirical evidence of study publication bias and outcome reporting bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Publication bias in editorial decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Why Most Discovered True Associations Are Inflated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Stopping rules and estimation problems in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Practical problems in interim analyses, with particular regard to estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Issues in comparisons between meta-analyses and large trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Uncertainty in heterogeneity estimates in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Undue reliance on I(2) in assessing heterogeneity may mislead

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Statistically significant papers in psychiatry were cited more often than others

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Medical journals and pharmaceutical companies: uneasy bedfellows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Variation in results from randomized, controlled trials: stochastic or systematic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Early stopping of randomized clinical trials for overt efficacy is problematic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

The fading of reported effectiveness. A meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Discussion sections in reports of controlled trials published in general medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYR095